Brinker Capital Investments’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.63M Buy
120,458
+37,636
+45% +$1.45M 0.04% 422
2025
Q1
$3.21M Buy
82,822
+61,735
+293% +$2.39M 0.03% 500
2024
Q4
$713K Buy
21,087
+3,581
+20% +$121K 0.01% 1213
2024
Q3
$716K Buy
17,506
+114
+0.7% +$4.66K 0.01% 1191
2024
Q2
$670K Buy
17,392
+795
+5% +$30.6K 0.01% 1168
2024
Q1
$712K Buy
16,597
+252
+2% +$10.8K 0.01% 1131
2023
Q4
$648K Sell
16,345
-1,486
-8% -$58.9K 0.01% 1114
2023
Q3
$646K Buy
17,831
+411
+2% +$14.9K 0.01% 1104
2023
Q2
$621K Buy
17,420
+3,722
+27% +$133K 0.01% 1141
2023
Q1
$487K Buy
13,698
+5,845
+74% +$208K 0.01% 1151
2022
Q4
$276K Buy
7,853
+653
+9% +$22.9K 0.01% 1180
2022
Q3
$212K Sell
7,200
-912
-11% -$26.9K ﹤0.01% 1261
2022
Q2
$441K Sell
8,112
-42,603
-84% -$2.32M 0.01% 1022
2022
Q1
$2.76M Buy
50,715
+1,505
+3% +$81.9K 0.04% 409
2021
Q4
$2.71M Buy
49,210
+3,843
+8% +$212K 0.04% 456
2021
Q3
$2.26M Hold
45,367
0.04% 517
2021
Q2
$2.26M Buy
45,367
+12,651
+39% +$631K 0.03% 570
2021
Q1
$1.47M Sell
32,716
-12,442
-28% -$558K 0.02% 585
2020
Q4
$2.08M Buy
45,158
+21,692
+92% +$1M 0.03% 548
2020
Q3
$1.11M Buy
+23,466
New +$1.11M 0.02% 655
2019
Q3
Sell
-659
Closed -$33K 834
2019
Q2
$33K Buy
659
+198
+43% +$9.92K ﹤0.01% 640
2019
Q1
$24K Buy
+461
New +$24K ﹤0.01% 531
2017
Q3
Sell
-4,942
Closed -$266K 586
2017
Q2
$266K Sell
4,942
-607
-11% -$32.7K 0.01% 267
2017
Q1
$292K Buy
5,549
+1,115
+25% +$58.7K 0.01% 256
2016
Q4
$213K Buy
4,434
+486
+12% +$23.3K 0.01% 259
2016
Q3
$213K Buy
+3,948
New +$213K 0.01% 253
2014
Q4
Sell
-2,813
Closed -$162K 432
2014
Q3
$162K Buy
+2,813
New +$162K 0.01% 251
2014
Q2
Sell
-2,410
Closed -$161K 388
2014
Q1
$161K Sell
2,410
-533
-18% -$35.6K 0.01% 265
2013
Q4
$196K Buy
2,943
+57
+2% +$3.8K 0.01% 261
2013
Q3
$181K Buy
2,886
+76
+3% +$4.77K 0.01% 261
2013
Q2
$175K Buy
+2,810
New +$175K 0.01% 264